Global Vasculitis Market Research and Forecast 2018-2023

 

Contact Information
Anurag Tiwari
116, Shagun Arcade, Vijay Nagar Square
Indore
Madhya Pradesh - 452001
India
+1-646-755-7667, +91-780-304-0404
info@omrglobal.com, support@omrglobal.com
 
Indore, July 2018: Orion Market Research (OMR), recently published a market research report on the Global vasculitis market. According to the OMR analysis, the Global vasculitis market is expected to grow at a significant rate during 2018-2023. The global vasculitis market has witnessed a significant growth due to increasing healthcare expenditure and research and development in vasculitis treatment. The Global Vasculitis Market is segmented on the basis type, diagnosis tests, therapeutic class, end user and geography. The report provides detailed and insightful chapters on Market Overview, Key Findings, Strategic Recommendations, Market Estimations, Market Determinants, Sector Analysis, Key Company Analysis, Market Insights, Company Profiling, Market Segmentation, Geographical Analysis, Analyst Insights and predictive analysis of the market.

“The presence of large number of pipeline products holds a huge opportunity for the growth of vasculitis market in the future. The product portfolio of the market players is flooded with new and innovative products. The market players are receiving approval by the government authorities such as FDA to continue their development and start their next phase of the product. For example: InflaRx N.V. received the US FDA approval in January 2018 for its Investigational New Drug (IND) application. This will allow the company to begin its planned phase II study for determining the efficacy and safety of IFX-1, a first-in-class anti-human complement factor C5a antibody, in patients living with ANCA-associated vasculitis (AAV).

The market on the basis of geography is divided among four major regions - North America, APAC, Europe, and Rest of the world. North America is the leading market. The market is expected to grow at a stable CAGR. North American market is driven by rising healthcare expenditure and research and development in vasculitis treatment. In addition, supportive reimbursement policies, as well as presence of key players in the region further augments the growth of vasculitis market in North America. Asia Pacific market is expected to have the highest CAGR amongst all regions for the forecasted period of 2018-2023. APAC market is driven by the increasing prevalence of microscopic polyangiitis (MPA) in the APAC region, especially in China and Japan.

The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, patent analysis, pipeline analysis, market determinants, key company analysis, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.”

About Orion Market Research

Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.
For more information, visit: https://www.omrglobal.com/industry-reports/vasculitis-market/


Healthcare, Medical Devices

 

If you have any questions regarding information in this press release, please contact the person listed in the Contact / Company information box of this page. Please do not attempt to contact Market Press Release. We will be unable to assist you with any information regarding this release. Market Press Release disclaims any content contained in this press release.